BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12619094)

  • 1. Lymphnode localization of extramedullary myeloid cell tumor in myelodysplastic syndrome: report of one case diagnosed by fine-needle cytology.
    Fulciniti F; Zeppa P; Marino G; Martinelli V; Ciancia R; Del Vecchio L; Rotoli B; Palombini L
    Diagn Cytopathol; 2003 Mar; 28(3):136-9. PubMed ID: 12619094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trilineage extramedullary myeloid cell tumor in myelodysplastic syndrome.
    Hancock JC; Prchal JT; Bennett JM; Listinsky CM
    Arch Pathol Lab Med; 1997 May; 121(5):520-3. PubMed ID: 9167610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A specific cutaneous lesion revealing myelodysplastic syndrome.
    Kajisawa C; Matsui C; Morohashi M
    Eur J Dermatol; 1998; 8(7):517-8. PubMed ID: 9854168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine needle aspiration of extramedullary myeloid cell tumor in myelodysplastic syndrome. A report of three cases.
    Gujral S; Kumar R; Jain P; Sharma A; Gupta S; Kumar L; Raina V; Kochupillai V
    Acta Cytol; 1999; 43(4):647-51. PubMed ID: 10432889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.
    Hofmann WK; Heil G; Zander C; Wiebe S; Ottmann OG; Bergmann L; Hoeffken K; Fischer JT; Knuth A; Kolbe K; Schmoll HJ; Langer W; Westerhausen M; Koelbel CB; Hoelzer D; Ganser A
    Ann Hematol; 2004 Aug; 83(8):498-503. PubMed ID: 15156346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of monocytic leukaemia cutis in a patient with myelodysplastic syndrome transforming to acute myeloid leukaemia.
    Perez A; Kennedy C; Standen G; Oxley J
    Clin Exp Dermatol; 2004 Sep; 29(5):497-8. PubMed ID: 15347335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Successful treatment of refractory anemia with excess of blasts in transformation with cytarabine ocfosfate].
    Takeuchi M; Kojima K; Takaba S; Isokawa M; Tanimizu M; Kimura F; Ohmoto E; Harada M
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):141-4. PubMed ID: 7826071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical Sweet's syndrome in a neutropenic patient with acute myeloid leukemia, secondary to a RAEB-T, simulating thrombophlebitis.
    Equitani F; Mele L; Rutella S; Belli P; Paciaroni K; Piscitelli R; Pagano L
    Panminerva Med; 1999 Sep; 41(3):261-3. PubMed ID: 10568127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soft tissue chloroma diagnosed by fine needle aspiration cytology. A case report.
    Kumar PV
    Acta Cytol; 1994; 38(1):83-6. PubMed ID: 8291361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia.
    Kuendgen A; Knipp S; Fox F; Strupp C; Hildebrandt B; Steidl C; Germing U; Haas R; Gattermann N
    Ann Hematol; 2005 Dec; 84 Suppl 1():61-6. PubMed ID: 16270213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Granulocytic sarcoma: a study of 5 cases].
    Tuset E; Ribera JM; Vaquero M; Jiménez C; Millá F; Juncá J; Flores A; Feliu E
    Med Clin (Barc); 1995 Mar; 104(10):377-80. PubMed ID: 7707732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
    Kröger N; Bornhäuser M; Ehninger G; Schwerdtfeger R; Biersack H; Sayer HG; Wandt H; Schäfer-Eckardt K; Beyer J; Kiehl M; Zander AR;
    Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Successful induction chemotherapy for childhood RAEB-T with VP-16: a case report].
    Tanizawa A; Sonomura T; Wakazono Y; Akiyama Y; Kubota M; Mikawa H
    Rinsho Ketsueki; 1989 Jul; 30(7):1052-7. PubMed ID: 2810790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).
    Ogasawara T; Yasuyama M; Kawauchi K
    Am J Hematol; 2005 Jun; 79(2):136-41. PubMed ID: 15929101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine needle aspiration cytology of extramedullary chronic myelogenous leukemia.
    Mourad WA; Sneige N; Huh YO; Katz RL; Caraway NP; Corck A; Wojcik E
    Acta Cytol; 1995; 39(4):706-12. PubMed ID: 7631544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
    Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
    Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory anaemia with excess of blasts in transformation re-evaluated with the WHO criteria: identification of subgroups with different survival.
    Breccia M; Latagliata R; Carmosino I; Gentilini F; D'Elia GM; Levi A; Natalino F; Frustaci A; De Cuia MR; Alimena G
    Acta Haematol; 2007; 117(4):221-5. PubMed ID: 17259693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia [AML]) on outcome of AML-type chemotherapy.
    Estey E; Thall P; Beran M; Kantarjian H; Pierce S; Keating M
    Blood; 1997 Oct; 90(8):2969-77. PubMed ID: 9376577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined low-dose cytarabine, melphalan and mitoxantrone for older patients with acute myeloid leukemia or high-risk myelodysplastic syndrome.
    Yamauchi T; Negoro E; Arai H; Ikegaya S; Takagi K; Takemura H; Inai K; Yoshida A; Urasaki Y; Iwasaki H; Ueda T
    Anticancer Res; 2007; 27(4C):2635-9. PubMed ID: 17695426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies.
    Pai RK; Mullins FM; Kim YH; Kong CS
    Cancer; 2008 Oct; 114(5):323-32. PubMed ID: 18798522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.